Clinical trial · Observational
Measurement of Implant Stability by Resonance Frequency Analysis in Patients Treated for an Upper Aero-digestive Tract Cancer
STABICAN : Measurement of Implant Stability by Analysis of the Resonance Frequency in Patients Treated for Cancer of the Upper Aero-digestive Tract
NCT04532359CI-TRIAL-00054481STABICANunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective is to describe the evolution of implant stability between the date of implant placement and 3 months later when the implant is implementated in patients treated for cancer of the upper aero-digestive tract
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Implant placement | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Evolution of implant stability in patients treated for cancer of the upper aero-digestive tract between placement and 3 months after placement
- timeFrame
- At 3 months after implant placement
- description
- Measure with Osstell Beacon device (Implant Stability Quotient : value from 1 to 100)
Secondary outcomes (2)
- measure
- Evaluation of the association between the type of bone (maxilla/mandible and fibula) and implant stability
- timeFrame
- At 3 months after implant placement
- description
- Correlation between the type of bone (maxilla / mandible and fibula) and implant stability
- measure
- Evaluation of the correlation between the irradiation dose received at the implant site and implant stability
- timeFrame
- At 3 months after implant placement
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient with squamous cell carcinoma of the upper aero-digestive tract (oral cavity, oropharynx, hypopharynx * Patient having been treated by external radiotherapy and/or having benefited from a microanastomosis fibula flap * Patient going to undergo a surgical intervention with placement of dental implant(s) in an irradiated area or in the microanastomosis fibula flap * Non-opposition to the study Exclusion Criteria: * Patient having difficulties speaking and understanding French * Patient under tutorship or curatorship
References
Publications (0)
Data not yet available
No reference posted for this study.